定位基因组分析确定了β(2) - 上腺素受体基因作为人类高血压的敏感位置
1Institute of Molecular Medicine, The University of Texas-Houston Health Science Center, Houston, Texas 77225, USA.
Circulation
|June 28, 2000
概括
贝塔2-上腺素受体基因的遗传变异与血压水平和高血压风险有关. 这些发现表明,该基因在血压调节中起着作用.
科学领域:
- 遗传学 遗传学 是一个
- 心血管科学 心血管科学
- 药物基因组学 药物基因组学
背景情况:
- 全基因组链接分析确定了与血压相关的染色体区域.
- 在这个区域内重新排序了五个位置候选基因.
研究的目的:
- 研究候选基因中的遗传变异与血压水平之间的关联.
- 为了确定影响高血压风险的特定基因多态性.
主要方法:
- 候选基因的重新测序和家族样本中变异的基因定型.
- 基于家庭的关联分析是使用核家庭和兄弟姐妹对进行的.
- 病例控制分析比较高血压和正常血压个体的等位基因频率.
主要成果:
- 贝塔2-上腺素受体基因 (Arg16Gly和Gln27Glu) 的多态性与静脉缩,静脉缩和平均动脉血压有显著的关联.
- 在β(2) - 上腺素受体基因中的Gln27Glu多态性显示出与高血压风险 (OR=1.80) 的显著关联.
- 对于谷氨过氧化酶3基因变异与血压水平没有发现显著的关联.
结论:
- 贝塔2-上腺素受体基因的变异与血压调节和高血压有关.
- 进一步研究影响血压的β(2) - 上腺素受体基因变异的机制性途径是有必要的.
更多相关视频
相关概念视频
Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


